Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nathalie Largeron, Karl Ulrich Petry, Jorge Jacob, Florence Bianic, Delphine Anger & Mathieu Uhart. (2017) An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany. Expert Review of Pharmacoeconomics & Outcomes Research 17:1, pages 85-98.
Read now
Read now
Didik Setiawan, Jos Luttjeboer, Tjalke Arend Westra, Jan C Wilschut, Auliya A Suwantika, Toos Daemen, Jarir Atthobari, Bob Wilffert & Maarten J Postma. (2015) The cost–effectiveness of HPV vaccination in addition to screening: a Dutch perspective. Expert Review of Vaccines 14:4, pages 589-604.
Read now
Read now
Articles from other publishers (13)
C. Vujovich-Dunn, H. Wand, J. M. L. Brotherton, H. Gidding, J. Sisnowski, R. Lorch, M. Veitch, V. Sheppeard, P. Effler, S. R. Skinner, A. Venn, C. Davies, J. Hocking, L. Whop, J. Leask, K. Canfell, L. Sanci, M. Smith, M. Kang, M. Temple-Smith, M. Kidd, S. Burns, L. Selvey, D. Meijer, S. Ennis, C. Thomson, N. Lane, J. Kaldor & R. Guy. (2022) Measuring school level attributable risk to support school-based HPV vaccination programs. BMC Public Health 22:1.
Crossref
Crossref
J. Sisnowski, C. Vujovich-Dunn, H. Gidding, J. Brotherton, H. Wand, R. Lorch, M. Veitch, V. Sheppeard, P. Effler, S.R Skinner, A. Venn, C. Davies, J. Hocking, L. Whop, J. Leask, K. Canfell, L. Sanci, M. Smith, M. Kang, M. Temple-Smith, M. Kidd, S. Burns, L. Selvey, D. Meijer, S. Ennis, C. Thomson, N. Lane, J. Kaldor & R. Guy. (2021) Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states. Vaccine 39:41, pages 6117-6126.
Crossref
Crossref
Stephanie Stephens, Anuja Chatterjee, Victoria Coles & Robin Crawford. (2020) The costs of treating vaginal and vulval cancer in England (2009–2015). BMC Public Health 20:1.
Crossref
Crossref
Marta Domenech-Viñolas, Leith León-Maldonado, Paula Ramírez-Palacios, Yvonne N Flores, Victor Granados-García, Brandon Brown, Edgar Corona, Stephanie Liu, Eduardo Lazcano-Ponce & Jorge Salmerón. (2018) Incidence, psychosocial burden, and economic impact of genital warts in Mexico. Salud Pública de México 60:6, nov-dic, pages 624.
Crossref
Crossref
P. Schneede. (2018) Krankheitslast humaner Papillomaviren der MännerHuman papillomavirus disease burden in men. Der Urologe 57:12, pages 1452-1456.
Crossref
Crossref
Noelia López, Ángel Gil-de-Miguel, Raquel Pascual-García, Jose Manuel Ramón y Cajal & Ruth Gil-Prieto. (2018) Hospitalization burden associated with malignant neoplasia and in situ carcinoma in vulva and vagina during a 5-year period (2009–2013) in Spain: An epidemiological study. Papillomavirus Research 5, pages 80-86.
Crossref
Crossref
Didik Setiawan, Arrum Dusafitri, Githa Fungie Galistiani, Antoinette D.I. van Asselt & Maarten J. Postma. (2018) Health-Related Quality of Life of Patients with HPV-Related Cancers in Indonesia. Value in Health Regional Issues 15, pages 63-69.
Crossref
Crossref
P. Schneede & B. Schlenker. (2018) Anogenitale Warzen und HPV-assoziierte PräkanzerosenAnogenital warts and HPV-associated precancers. Der Urologe 57:4, pages 453-457.
Crossref
Crossref
S.T. Keeping, M.J. Tempest, S.J. Stephens, S.M. Carroll, R. Simcock, T.M. Jones & R. Shaw. (2017) The cost of oropharyngeal cancer in England: A retrospective hospital data analysis. Clinical Otolaryngology 43:1, pages 223-229.
Crossref
Crossref
Didik Setiawan, Franklin Christiaan Dolk, Auliya A. Suwantika, Tjalke Arend Westra, Jan C. WIlschut & Maarten Jacobus Postma. (2016) Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia. Value in Health Regional Issues 9, pages 84-92.
Crossref
Crossref
Rong Wang, Xiao-lei Guo, G. Bea. A. Wisman, Ed Schuuring, Wen-feng Wang, Zheng-yu Zeng, Hong Zhu & Shang-wei Wu. (2015) Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infectious Diseases 15:1.
Crossref
Crossref
Carlos A. R. Veo, Sarhan S. Saad, José Humberto T. G. Fregnani, Cristovam Scapulatempo-Neto, Audrey Tieko Tsunoda, Júlio César Possati Resende, Adriana Tarlá Lorenzi, Allini Mafra, Claudia Cinti, Ismael Dale Cotrim, Luciana Albina Reis Rosa, Cristina Mendes de Oliveira, Toni Ricardo Martins, Cristiane Centrone, José Eduardo Levi & Adhemar Longatto-Filho. (2015) Clinical characteristics of women diagnosed with carcinoma who tested positive for cervical and anal high-risk human papillomavirus DNA and E6 RNA. Tumor Biology 36:7, pages 5399-5405.
Crossref
Crossref
Jakob Kirkegård, Dora Körmendiné Farkas, Mette Søgaard, Sigrún Alba Jóhannesdóttir Schmidt, Eva Bjerre Ostenfeld & Deirdre Cronin-Fenton. (2014) Conization as a marker of persistent cervical human papillomavirus (HPV) infection and risk of gastrointestinal cancer: a Danish 34-year nationwide cohort study. Cancer Causes & Control 25:12, pages 1677-1682.
Crossref
Crossref